← Leaderboards
Ethan Lippmann
University Of Wisconsin-Madison
$8,201,254
Attributed
$12,588,888
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2013–25$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,588,888 · 10
By mechanism
RF1$6,366,859 · 2
R01$4,011,693 · 3
R21$1,287,411 · 3
R61$831,660 · 1
F32$91,265 · 1
Top collaborators
- Matthew Schrag5 shared
- Craig Lewis Duvall3 shared
- Jonathan Matthew Brunger2 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Pamela Herd$27,921,200
- Barbara Brigitta Bendlin$36,811,854
- Amy J. Kind$26,736,068
- Andrea L Gilmore-Bykovskyi$4,457,839
- Nicole M Rogus-Pulia$4,286,234
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposCellsIn VivoExhibitsS DiseaseBrainNeurovascularBlood VesselsTissuesMolecularInduced Pluripotent Stem Cell3-DimensionalPreventIn VitroBlood - Brain Barrier AnatomyImageSignal TransductionFunctional DisorderIn Vivo ModelEndothelial CellsIn Vitro ModelMouse ModelBrain Endothelial CellNerve Degeneration
Grant awards (22)
Perivascular fibroblasts, vascular fibrosis, and their contributions to cerebral amyloid angiopathy$1,517,868
RF1 · FY2025 · NS · contact PI
Targeting brain myeloid cells with siRNA-lipid conjugates for treatment of Alzheimer's disease$787,103
R01 · FY2025 · AG · contact PI
STAT3 activation in astrocytes as a driver of neurovascular dysfunction in Alzheimer's disease and related dementias$765,645
R01 · FY2025 · NS · contact PI
Engineering developmentally-relevant Wnt signaling events to improve iPSC-derived blood-brain barrier models$198,125
R21 · FY2025 · NS · contact PI
iPSC-derived Neurovascular Organoids$443,089
R01 · FY2024 · NS · contact PI
Engineering developmentally-relevant Wnt signaling events to improve iPSC-derived blood-brain barrier models$237,750
R21 · FY2024 · NS · contact PI
iPSC-derived Neurovascular Organoids$444,774
R01 · FY2023 · NS · contact PI
Albumin hitchhiking siRNAs for gene targeting in aged brain$190,001
R21 · FY2023 · AG · contact PI
STAT3 activation in astrocytes as a driver of neurovascular dysfunction in Alzheimer's disease and related dementias$170,184
RF1 · FY2023 · NS · contact PI
iPSC-derived Neurovascular Organoids$122,028
R01 · FY2023 · NS · contact PI
STAT3 activation in astrocytes as a driver of neurovascular dysfunction in Alzheimer's disease and related dementias$2,345,579
RF1 · FY2022 · NS · contact PI
Perivascular fibroblasts, vascular fibrosis, and their contributions to cerebral amyloid angiopathy$2,333,228
RF1 · FY2022 · NS · contact PI
iPSC-derived Neurovascular Organoids$447,401
R01 · FY2022 · NS · contact PI
Albumin hitchhiking siRNAs for gene targeting in aged brain$229,785
R21 · FY2022 · AG · contact PI
iPSC-derived Neurovascular Organoids$108,523
R01 · FY2022 · NS · contact PI
iPSC-derived Neurovascular Organoids$447,019
R01 · FY2021 · NS · contact PI
iPSC-derived neurovascular tissue model of cerebral amyloiad angiopathy$831,660
R61 · FY2020 · NS · contact PI
iPSC-derived Neurovascular Organoids$446,111
R01 · FY2020 · NS · contact PI
Elucidating Novel Human Blood-Brain Barrier Components$196,250
R21 · FY2019 · NS · contact PI
Elucidating Novel Human Blood-Brain Barrier Components$235,500
R21 · FY2018 · NS · contact PI
Modeling spinal cord axis patterning with human pluripotent stem cells$42,051
F32 · FY2015 · NS · contact PI
Modeling spinal cord axis patterning with human pluripotent stem cells$49,214
F32 · FY2013 · NS · contact PI